REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
07/08/2026
Voltar para busca
Dado oficial do USPTO
MESOBLAST
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
55
Atualização mais recente
07/08/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 42
Data de depósito
30/03/2005
Data de registro
07/08/2007
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
10/08/2017
Última transação
07/08/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
MELBOURNE Victoria, AU
Examinador
HOFFMAN, DAVID AARON
Unidade examinadora
L70
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
Mesoblast Limited
Mesoblast Limited
Representantes
Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for the preventionmanagementdiagnosis and treatment of connective tissue and musco-skeletal disorders and indications; veterinary preparations for the preventionmanagementdiagnosis and treatment of connective tissue and musco-skeletal disorders and indications; biotechnology preparations for the preventionmanagementdiagnosis and treatment of connective tissue and musco-skeletal disorders and indications; medical preparations for the preventionmanagementdiagnosis and treatment of connective tissue and musco-skeletal disorders and indications; diagnostic preparations and reagents for medical purposes; culture fluidscultures of micro-organisms for medical purposes; human allograft tissue; animal allograft tissue; human tissue and animal tissue for transplantation or implantationmedical and surgical purposes; human cells including stem cellsanimal cells including stem cells for medical or clinical use; pharmaceutical preparations for the treatmentreconstruction and repair of tissue
Classe 42
Scientificmedical researchclinical researchpharmaceutical research and developmentadvisory and consultancy services in the field of T-cell productionT-cell immunotherapycell culture devicestissue engineering for cellular applications for humans and animalsstem cell bankingtissue bankingdrug discoveryvaccine screeningcell culture methodscell expansion technology including stem cell expansion technologycellular therapies including stem cell therapies and cellular transplants
Publicações
Histórico de despachos e eventos da marca no USPTO.
55 publicações encontradas
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
26/05/2026
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
11/04/2025
RNWL
INTERNATIONAL REGISTRATION RENEWED
03/04/2025
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
10/08/2017
71AG
REGISTERED-SEC.71 ACCEPTED
10/08/2017
ES71
TEAS SECTION 71 RECEIVED
07/08/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/07/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
25/05/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
25/05/2017
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
07/08/2016
NREP
NEW REPRESENTATIVE AT IB RECEIVED
17/07/2015
RNWL
INTERNATIONAL REGISTRATION RENEWED
16/04/2015
NREP
NEW REPRESENTATIVE AT IB RECEIVED
29/11/2013
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
21/03/2013
71AG
REGISTERED-SEC.71 ACCEPTED
21/03/2013
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
21/03/2013
PR71
POST REGISTRATION ACTION MAILED - SEC.71
15/01/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
15/01/2013
ES71
TEAS SECTION 71 RECEIVED
24/12/2012
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
24/12/2012
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
23/12/2011
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
26/02/2009
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/12/2007
FIMP
FINAL DISPOSITION PROCESSED
05/12/2007
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
19/11/2007
EXPT
EXPARTE APPEAL TERMINATED
07/08/2007
R.PR
REGISTERED-PRINCIPAL REGISTER
07/08/2007
PAPER RECEIVED
01/08/2007
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
14/06/2007
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
31/05/2007
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
31/05/2007
PUBO
PUBLISHED FOR OPPOSITION
22/05/2007
NPUB
NOTICE OF PUBLICATION
02/05/2007
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
22/03/2007
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
22/03/2007
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/03/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/03/2007
ALIE
ASSIGNED TO LIE
20/03/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
16/02/2007
EXPI
EX PARTE APPEAL-INSTITUTED
16/02/2007
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
16/02/2007
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
16/02/2007
CNFR
FINAL REFUSAL MAILED
17/08/2006
CNFR
FINAL REFUSAL WRITTEN
16/08/2006
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/07/2006
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/07/2006
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
16/07/2006
RFNT
REFUSAL PROCESSED BY IB
03/02/2006
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
17/01/2006
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/01/2006
CNRT
NON-FINAL ACTION WRITTEN
11/01/2006
DOCK
ASSIGNED TO EXAMINER
03/01/2006
NWAP
NEW APPLICATION ENTERED
03/01/2006
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
30/12/2005
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MESOBLAST ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.